Производство рекомбинантного человеческого инсулина

Биотехнология и фармацевтическое производство

Pharmaceutical & Drug Manufacturing Global Industrial Scale $35 billion

Обзор

Recombinant human insulin is produced using genetically engineered Escherichia coli or Saccharomyces cerevisiae that express the human insulin gene. This biotechnological process replaced the previous method of extracting insulin from pig and cow pancreases, providing unlimited supply with reduced immunogenicity. The process involves fermentation, cell lysis, inclusion body solubilization, refolding, enzymatic modification, and multi-step chromatographic purification to produce pharmaceutical-grade insulin.

Химический процесс

E. coli expressing proinsulin genes are fermented in large bioreactors. Inclusion bodies containing proinsulin are isolated, solubilized in urea, and the protein is refolded by controlled oxidation. Trypsin and carboxypeptidase B cleave the C-peptide to yield mature insulin, which is purified by reversed-phase and ion-exchange chromatography.

Proinsulin →[Trypsin + Carboxypeptidase B] Insulin (A-chain + B-chain linked by disulfide bonds) + C-peptide

Сырьё

  • Glucose (C₆H₁₂O₆) — Corn processing (Carbon source for fermentation)
  • Ammonium sulfate ((NH₄)₂SO₄) — Chemical synthesis (Nitrogen source)
  • Trypsin (enzyme) — Recombinant production (C-peptide cleavage)

Конечные продукты

  • Recombinant human insulin — Diabetes treatment (>98% purity, multiple analog forms)
<path stroke-linecap="round" stroke-linejoin="round" d="M12 9v3.75m-9.303 3.376c-.866 1.5.217 3.374 1.948 3.374h14.71c1.73 0 2.813-1.874 1.948-3.374L13.949 3.378c-.866-1.5-3.032-1.5-3.898 0L2.697 16.126zM12 15.75h.007v.008H12v-.008z" />

Environmental Impact

Fermentation-based production generates biological waste requiring sterilization before disposal. Chromatographic purification consumes significant water and buffer solutions. However, the environmental impact is far less than animal-sourced insulin which required millions of animal pancreases annually.

Соображения безопасности

Последние инновации

Insulin analogs (lispro, glargine, aspart) with modified amino acid sequences provide faster or longer-acting profiles.
Cell-free protein synthesis and oral insulin delivery systems are in advanced development stages.

Больше в Pharmaceutical & Drug Manufacturing

Полусинтетическое производство амоксициллина

Global Industrial Scale

Производство пенициллина G методом ферментации

Global Industrial Scale

Синтез аспирина ацетилированием салициловой кислоты

Global Industrial Scale

Синтез ибупрофена — зелёный процесс BHC

Global Industrial Scale

Синтез метформина гидрохлорида

Global Industrial Scale

Синтез омепразола для ингибиторов протонной помпы

Global Industrial Scale

Синтез парацетамола (ацетаминофена)

Global Industrial Scale

Frequently Asked Questions

What industry uses Производство рекомбинантного человеческого инсулина?
Производство рекомбинантного человеческого инсулина is used in the pharmaceutical & drug manufacturing sector at global industrial scale scale.
What process is involved in Производство рекомбинантного человеческого инсулина?
E. coli expressing proinsulin genes are fermented in large bioreactors. Inclusion bodies containing proinsulin are isolated, solubilized in urea, and the protein is refolded by controlled oxidation. Trypsin and carboxypeptidase B cleave the C-peptide to yield mature insulin, which is purified by rev
What is the economic significance of Производство рекомбинантного человеческого инсулина?
Производство рекомбинантного человеческого инсулина has a market value of $35 billion.
What is the environmental impact of Производство рекомбинантного человеческого инсулина?
Fermentation-based production generates biological waste requiring sterilization before disposal. Chromatographic purification consumes significant water and buffer solutions. However, the environmental impact is far less than animal-sourced insulin which required millions of animal pancreases annua
What raw materials are used in Производство рекомбинантного человеческого инсулина?
The main raw materials include: Glucose (C₆H₁₂O₆), Ammonium sulfate ((NH₄)₂SO₄), Trypsin (enzyme).